319 related articles for article (PubMed ID: 19735360)
1. N-Methyl-D-aspartate receptor antagonism decreases motility and inflammatory activation in the early phase of acute experimental colitis in the rat.
Varga G; Erces D; Fazekas B; Fülöp M; Kovács T; Kaszaki J; Fülöp F; Vécsei L; Boros M
Neurogastroenterol Motil; 2010 Feb; 22(2):217-25, e68. PubMed ID: 19735360
[TBL] [Abstract][Full Text] [Related]
2. N-methyl-D-aspartate receptor antagonist therapy suppresses colon motility and inflammatory activation six days after the onset of experimental colitis in rats.
Érces D; Varga G; Fazekas B; Kovács T; Tőkés T; Tiszlavicz L; Fülöp F; Vécsei L; Boros M; Kaszaki J
Eur J Pharmacol; 2012 Sep; 691(1-3):225-34. PubMed ID: 22796676
[TBL] [Abstract][Full Text] [Related]
3. Kynurenic acid inhibits intestinal hypermotility and xanthine oxidase activity during experimental colon obstruction in dogs.
Kaszaki J; Palásthy Z; Erczes D; Rácz A; Torday C; Varga G; Vécsei L; Boros M
Neurogastroenterol Motil; 2008 Jan; 20(1):53-62. PubMed ID: 17973632
[TBL] [Abstract][Full Text] [Related]
4. Dietary phosphatidylcholine supplementation attenuates inflammatory mucosal damage in a rat model of experimental colitis.
Kovács T; Varga G; Erces D; Tőkés T; Tiszlavicz L; Ghyczy M; Boros M; Kaszaki J
Shock; 2012 Aug; 38(2):177-85. PubMed ID: 22576006
[TBL] [Abstract][Full Text] [Related]
5. Effect of N-methyl-d-aspartate receptor blockade on neuronal plasticity and gastrointestinal transit delay induced by ischemia/reperfusion in rats.
Calcina F; Barocelli E; Bertoni S; Furukawa O; Kaunitz J; Impicciatore M; Sternini C
Neuroscience; 2005; 134(1):39-49. PubMed ID: 15939544
[TBL] [Abstract][Full Text] [Related]
6. [Comparative study of novel therapeutic possibilities in animal experimental model of inflammatory bowel disease].
Kovács T; Varga G; Erces D; Tőkés T; Tiszlavicz L; Ghyczy M; Vécsei L; Boros M; Kaszaki J
Magy Seb; 2012 Aug; 65(4):191-7. PubMed ID: 22940387
[TBL] [Abstract][Full Text] [Related]
7. Influence of simultaneous inhibition of cyclooxygenase-2 and inducible nitric oxide synthase in experimental colitis in rats.
Dudhgaonkar SP; Tandan SK; Kumar D; Raviprakash V; Kataria M
Inflammopharmacology; 2007 Oct; 15(5):188-95. PubMed ID: 17943250
[TBL] [Abstract][Full Text] [Related]
8. Sex steroid regulation of macrophage migration inhibitory factor in normal and inflamed colon in the female rat.
Houdeau E; Moriez R; Leveque M; Salvador-Cartier C; Waget A; Leng L; Bueno L; Bucala R; Fioramonti J
Gastroenterology; 2007 Mar; 132(3):982-93. PubMed ID: 17324399
[TBL] [Abstract][Full Text] [Related]
9. Role of TNF-alpha in muscularis inflammation and motility disorder in a TNBS-induced colitis model: clues from TNF-alpha-deficient mice.
Kinoshita K; Hori M; Fujisawa M; Sato K; Ohama T; Momotani E; Ozaki H
Neurogastroenterol Motil; 2006 Jul; 18(7):578-88. PubMed ID: 16771773
[TBL] [Abstract][Full Text] [Related]
10. Changes in colonic motility and the electrophysiological properties of myenteric neurons persist following recovery from trinitrobenzene sulfonic acid colitis in the guinea pig.
Krauter EM; Strong DS; Brooks EM; Linden DR; Sharkey KA; Mawe GM
Neurogastroenterol Motil; 2007 Dec; 19(12):990-1000. PubMed ID: 17973636
[TBL] [Abstract][Full Text] [Related]
11. PARP inhibition reduces acute colonic inflammation in rats.
Sánchez-Fidalgo S; Villegas I; Martín A; Sánchez-Hidalgo M; Alarcón de la Lastra C
Eur J Pharmacol; 2007 Jun; 563(1-3):216-23. PubMed ID: 17374531
[TBL] [Abstract][Full Text] [Related]
12. Suppression of acute experimental colitis by a highly selective inducible nitric-oxide synthase inhibitor, N-[3-(aminomethyl)benzyl]acetamidine.
Kankuri E; Vaali K; Knowles RG; Lähde M; Korpela R; Vapaatalo H; Moilanen E
J Pharmacol Exp Ther; 2001 Sep; 298(3):1128-32. PubMed ID: 11504810
[TBL] [Abstract][Full Text] [Related]
13. Enteral diets enriched with medium-chain triglycerides and N-3 fatty acids prevent chemically induced experimental colitis in rats.
Kono H; Fujii H; Ogiku M; Tsuchiya M; Ishii K; Hara M
Transl Res; 2010 Nov; 156(5):282-91. PubMed ID: 20970751
[TBL] [Abstract][Full Text] [Related]
14. The effect of the cholinergic anti-inflammatory pathway on experimental colitis.
Bai A; Guo Y; Lu N
Scand J Immunol; 2007 Nov; 66(5):538-45. PubMed ID: 17953529
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory intestinal activity of Abarema cochliacarpos (Gomes) Barneby & Grimes in TNBS colitis model.
da Silva MS; Sánchez-Fidalgo S; Talero E; Cárdeno A; da Silva MA; Villegas W; Souza Brito AR; de La Lastra CA
J Ethnopharmacol; 2010 Mar; 128(2):467-75. PubMed ID: 20083187
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone, a PPARgamma ligand, modulates signal transduction pathways during the development of acute TNBS-induced colitis in rats.
Sánchez-Hidalgo M; Martín AR; Villegas I; de la Lastra CA
Eur J Pharmacol; 2007 May; 562(3):247-58. PubMed ID: 17343846
[TBL] [Abstract][Full Text] [Related]
17. Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis.
Isozaki Y; Yoshida N; Kuroda M; Handa O; Takagi T; Kokura S; Ichikawa H; Naito Y; Okanoue T; Yoshikawa T
Scand J Gastroenterol; 2006 Aug; 41(8):944-53. PubMed ID: 16803693
[TBL] [Abstract][Full Text] [Related]
18. eNOS involved in colitis-induced mucosal blood flow increase.
Petersson J; Schreiber O; Steege A; Patzak A; Hellsten A; Phillipson M; Holm L
Am J Physiol Gastrointest Liver Physiol; 2007 Dec; 293(6):G1281-7. PubMed ID: 17947450
[TBL] [Abstract][Full Text] [Related]
19. 1,8-cineole (eucalyptol), a monoterpene oxide attenuates the colonic damage in rats on acute TNBS-colitis.
Santos FA; Silva RM; Campos AR; De Araújo RP; Lima Júnior RC; Rao VS
Food Chem Toxicol; 2004 Apr; 42(4):579-84. PubMed ID: 15019181
[TBL] [Abstract][Full Text] [Related]
20. Dietary medium-chain triglycerides prevent chemically induced experimental colitis in rats.
Kono H; Fujii H; Ishii K; Hosomura N; Ogiku M
Transl Res; 2010 Mar; 155(3):131-41. PubMed ID: 20171598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
